Takeda Pharmaceutical Company Limited, a leading pharmaceutical company headquartered in Tokyo, Japan, operates globally with a focus on research, development, manufacturing, marketing, and out-licensing of pharmaceutical products. The company's products range from gastroenterology to rare diseases, plasma-derived therapies, oncology, and neuroscience, with leading brands such as Entyvio, Alofisel, and Vyvansese. Takeda has entered into collaboration, licensing, and strategic alliance agreements with numerous leading pharmaceutical companies, research institutions, and biotech firms. These include Neurocrine Biosciences, Inc., the University of Texas MD Anderson Cancer Center, and Egle Therapeutics SAS among others. The company was founded in 1781 and continues to expand its global presence with operations in the United States, Europe, Canada, Latin America, Russia, and Asia.